Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2010
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
About
Zingenix is a company focused on gene therapy for severe orphan disorders, including Duchenne Muscular Dystrophy (DMD). The company's technology is based on delivering artificial transcription factors by AAV to muscle cells for the up-regulation of utrophin. Zingenix was previously known as ILIT Bio Ventures Ltd.
Q&A
- What is Zingenix Ltd.'s primary focus?
- Zingenix Ltd. is a biotechnology company focused on developing gene therapies for severe orphan disorders, including Duchenne Muscular Dystrophy (DMD).
- What is the core technology behind Zingenix Ltd.'s gene therapy?
- Zingenix Ltd.'s technology is based on delivering artificial transcription factors by AAV to muscle cells for the up-regulation of utrophin.
- When was Zingenix Ltd. founded?
- Zingenix Ltd. was founded in 2010.
- Where is Zingenix Ltd. headquartered?
- Zingenix Ltd. is headquartered in Tel Aviv, Israel.
- Who are the co-founders of Zingenix Ltd.?
- The co-founders of Zingenix Ltd. are Yoram Azulai and Avraham Landa, both appointed in 2009.
- Who is the current CEO of Zingenix Ltd.?
- Robert Heft has served as the CEO of Zingenix Ltd. since 2014.
- What was Zingenix Ltd. previously known as?
- Zingenix Ltd. was previously known as ILIT Bio Ventures Ltd.
Team · 4
Yoram Azulai
Founder · Co-Founder
Avraham Landa
Founder · Co-Founder
Robert Heft
CEO
Yaffa Beck
CTO
Sectors & technology
Primary sector
Biotechnology
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | linkedin.com/in/avraham-landa-b3045a36/ |
|---|
Identifiers & details
| Founded | 2010 |
|---|